IGF-1 is associated with fetal growth and preterm delivery in type 1 diabetic pregnancy

References

• Madazli R, Kuseyrioglu B, Uzun H, et al. Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry. Int J Gynaecol Obstet 2005;89:251–7
   PubMed Web of Science ®Google Scholar
• Kaaja R. Predictors and risk factors of pre-eclampsia. Minerva Ginecol 2008;60:421–9
   PubMedGoogle Scholar
• Cooley SM, Donnelly JC, Collins C, et al. The relationship between maternal insulin-like growth factors 1 and 2 (IGF-1, IGF-2) and IGFBP-3 to gestational age and preterm delivery. J Perinat Med 2010;38:255–9
   PubMed Web of Science ®Google Scholar
• Halhali A, Tovar AR, Torres N, et al. Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 2000;85:1828–33
   PubMed Web of Science ®Google Scholar
• Kocyigit Y, Bayhan G, Atamer A, Atamer Y. Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance. Gynecol Endocrinol 2004;18:341–8
   PubMed Web of Science ®Google Scholar
• Kirkegaard I, Henriksen TB, Tørring N, Uldbjerg N. PAPP-A and free β-hCG measured prior to 10 weeks is associated with preterm delivery and small-for-gestational-age infants. Prenat Diagn 2011;31:171–5
   PubMed Web of Science ®Google Scholar
• Canini S, Prefumo F, Pastorino D, et al. Association between birth weight and first-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Fertil Steril 2008;89:174–8
   PubMed Web of Science ®Google Scholar
• Caufriez A, Frankenne F, Hennen G, Copinschi G. Regulation of maternal insulin-like growth factor I by placental growth hormone in pregnancy. Possible action of maternal IGF-I on fetal growth. Horm Res 1994;42:62–5
   PubMedGoogle Scholar
• Chellakooty M, Vangsgaard K, Larsen T, et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab 2004;89:384–91
   PubMed Web of Science ®Google Scholar
• Fuglsang J, Lauszus F, Flyvbjerg A, Ovesen P. Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes. J Clin Endocrinol Metab 2003;88:4355–61
   Web of Science ®Google Scholar
• Nielsen GL, Møller M, Sørensen HT. HbA1c in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes. Diabetes Care 2006;29:2612–16
   PubMed Web of Science ®Google Scholar
• Teramo K, Kari MA, Eronen M, et al. High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies. Diabetologia 2004;47:1695–703
   PubMed Web of Science ®Google Scholar
• Gordin D, Hiilesmaa V, Fagerudd J, et al.; FinnDiane Study Group. Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women. Diabetologia 2007;50:516–22
   PubMed Web of Science ®Google Scholar
• Frystyk J, Dinesen B, Ørskov H. Non-competitive time-resolved immunofluorometric assays for determination of human IGF-I and -II. Growth Reg 1995;5:169–76
   PubMedGoogle Scholar
• Teramo KA, Widness JA. Increased fetal plasma and amniotic fluid erythropoietin concentrations: markers of intrauterine hypoxia. Neonatology 2009;95:105–16
   PubMed Web of Science ®Google Scholar
• Kirkegaard I, Uldbjerg N, Oxvig C. Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview. Acta Obstet Gynecol Scand 2010;89:1118–25
   PubMed Web of Science ®Google Scholar
• Pedersen JF, Sorensen S, Ruge S. Human placental lactogen and pregnancy-associated plasma protein A in first trimester and subsequent fetal growth. Acta Obstet Gynecol Scand 1995;74:505–8
   PubMed Web of Science ®Google Scholar
• Kuc S, Wortelboer EJ, Koster MP, et al. Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation. BJOG 2011;118:748–54
   PubMed Web of Science ®Google Scholar
• Pedersen JF, Sorensen S, Mølsted-Pedersen L. Serum levels of human placental lactogen, pregnancy-associated plasma protein A and endometrial secretory protein PP14 in first trimester of diabetic pregnancy. Acta Obstet Gynecol Scand 1998;77:155–8
   PubMed Web of Science ®Google Scholar
• Boyne MS, Thame M, Bennett FI, et al. The relationship among circulating insulin-like growth factor (IGF)-I, IGF-binding proteins-1 and -2, and birth anthropometry: a prospective study. J Clin Endocrinol Metab 2003;88:1687–91
   PubMed Web of Science ®Google Scholar
• Orbak Z, Darcan S, Coker M, Gökşen D. Maternal and fetal serum insulin-like growth factor-I (IGF-I) IGF binding protein-3 (IGFBP-3), leptin levels and early postnatal growth in infants born asymmetrically small for gestational age. J Pediatr Endocrinol Metab 2001;14:1119–27
   PubMed Web of Science ®Google Scholar
• McIntyre HD, Zeck W, Russell A. Placental growth hormone, fetal growth and the IGF axis in normal and diabetic pregnancy. Curr Diabetes Rev 2009;5:185–9
   PubMedGoogle Scholar
• Ekbom P, Damm P, Nørgaard K, et al. Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in Type I diabetes. Diabetologia 2000;43:927–31
   PubMed Web of Science ®Google Scholar
• Jensen DM, Damm P, Ovesen P, et al. Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study. Diabetes Care 2010;33:90–4
   PubMed Web of Science ®Google Scholar
• Talaviya PA, Saboo BD, Joshi SR, et al. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment. Diabetes Metab Syndr 2013;7:68–71
   PubMedGoogle Scholar
• Chico A, Saigi I, García-Patterson A, et al. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin. Diabetes Technol Ther 2010;12:937–45
   PubMed Web of Science ®Google Scholar
• Maresh MJ, Holmes VA, Patterson CC, et al.; for the Diabetes and Pre-eclampsia Intervention Trial Study Group. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care 2015;38:34–42
   PubMed Web of Science ®Google Scholar
• Damm P, Mersebach H, Råstam J, et al. Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester. J Matern Fetal Neonatal Med 2014;27:149–54
   PubMed Web of Science ®Google Scholar
• Jovanovic L, Knopp RH, Brown Z, et al.; National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study Group. Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care 2001;24:4
   Web of Science ®Google Scholar